GleamWall
中文EN

RKDA Arcadia Biosciences, Inc.

Beverages · Nasdaq · SEC CIK 1469443 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.1%
TTM net income YoY-101.9%
TTM EPS YoY9.4%
Revenue 3-yr CAGR3.5%
Net income 3-yr CAGR—

Margins

Gross margin41.1%
Operating margin-68.9%
Net margin-202.1%
FCF margin—
EBITDA margin-68.7%

Returns

ROE-260.8%
ROA-153.9%
ROIC (approx.)-142.0%
Asset turnover0.76x

Leverage & solvency

Liabilities / assets49.0%
Debt / equity0.00x
Current ratio3.58x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio-100.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.62M$1.44M$1.10M$901,000$1.30M$1.46M$1.20M$1.22M
Cost of revenue$760,000$812,000$700,000$709,000$884,000$824,000$682,000$827,000
Gross profit$859,000$631,000$400,000$192,000$418,000$631,000$518,000$389,000
R&D expense$0$0—$0$0$9,000$0$13,000
SG&A expense$1.70M$1.13M$1.18M$1.57M$1.57M$2.12M$1.74M$2.65M
Operating income-$839,000-$496,000-$779,000-$1.38M-$1.15M-$501,000$530,000-$2.28M
Pretax income———————-$4.03M
Income tax———————$8,000
Net income$1.75M-$6.27M-$4.38M-$1.34M$856,000-$4.46M$2.60M-$4.06M
EBITDA-$839,000-$496,000-$771,000-$1.37M-$1.15M-$486,000$543,000-$2.31M
EPS (basic)0.29-2.09-2.11—0.63-3.261.90—
EPS (diluted)0.29-2.09-2.11—0.62-3.261.90—
Weighted avg. shares (diluted)6.07M2.99M2.08M—1.37M1.37M1.37M—
Banking
Net interest income$20,000$2,000$5,000-$1,000$7,000$9,000$207,000$354,000
Balance sheet
Cash & equivalents$2.84M$4.18M$954,000$259,000$1.12M$1.38M$3.16M$4.24M
Short-term investments$0$0$2.77M$4.30M$4.76M$3.07M—$0
Inventory$973,000$930,000$840,000$1.21M$1.46M$1.49M$1.28M$904,000
Current assets$4.56M$5.74M$5.17M$6.36M$8.39M$7.58M$8.85M$9.24M
PP&E, net$0$0$0$8,000$10,000$12,000$28,000$41,000
Intangibles$39,000$39,000$39,000$39,000$39,000$39,000$39,000$39,000
Total assets$4.72M$5.89M$5.32M$6.55M$8.58M$7.79M$12.99M$13.52M
Current liabilities$1.27M$1.65M$1.36M$2.06M$2.29M$1.84M$2.22M$2.56M
Total liabilities$2.31M$5.26M$2.44M$2.41M$3.14M$3.25M$4.08M$7.29M
Shareholders' equity$2.40M$633,000$2.88M$4.14M$5.44M$4.53M$8.90M$6.22M
Shares outstanding5.13M2.18M2.06M1.37M1.37M1.37M1.37M1.36M
Cash flow statement
Operating cash flow-$1.28M-$319,000-$1.10M-$861,000-$257,000-$2.03M-$1.59M-$2.21M
Capital expenditure———$0$0$0$0$0
Free cash flow———-$861,000-$257,000-$2.03M-$1.59M-$2.21M
Investing cash flow$0$0$0$0$0$250,000$500,000$2.52M
Financing cash flow-$55,000$3.54M$1.79M$0$1,000$0$5,000$0
Depreciation & amortization$0$0$8,000$2,000$2,000$15,000$13,000-$34,000
Stock-based compensation$14,000$14,000$15,000$17,000$53,000$86,000$78,000$117,000

Free plan shows the latest 8 periods; Pro shows all 51 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.